123 related articles for article (PubMed ID: 16574417)
1. Structure basis for the inhibitory mechanism of a novel DNase gamma-specific inhibitor, DR396.
Sunaga S; Yoshimori A; Shiokawa D; Tanuma S
Bioorg Med Chem; 2006 Jun; 14(12):4217-26. PubMed ID: 16574417
[TBL] [Abstract][Full Text] [Related]
2. A novel inhibitor that protects apoptotic DNA fragmentation catalyzed by DNase gamma.
Sunaga S; Kobayashi T; Yoshimori A; Shiokawa D; Tanuma S
Biochem Biophys Res Commun; 2004 Dec; 325(4):1292-7. PubMed ID: 15555567
[TBL] [Abstract][Full Text] [Related]
3. DR396, an apoptotic DNase γ inhibitor, attenuates high mobility group box 1 release from apoptotic cells.
Yamada Y; Fujii T; Ishijima R; Tachibana H; Yokoue N; Takasawa R; Tanuma S
Bioorg Med Chem; 2011 Jan; 19(1):168-71. PubMed ID: 21167721
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RuBisCO cloned from Thermosynechococcus vulcanus and expressed in Escherichia coli with compounds predicted by Molecular Operation Environment (MOE).
Iwaki T; Shiota K; Al-Taweel K; Kobayashi D; Kobayashi A; Suzuki K; Yui T; Wadano A
J Biosci Bioeng; 2008 Jan; 105(1):26-33. PubMed ID: 18295716
[TBL] [Abstract][Full Text] [Related]
7. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors.
Bharatham K; Bharatham N; Park KH; Lee KW
J Mol Graph Model; 2008 Jun; 26(8):1202-12. PubMed ID: 18096420
[TBL] [Abstract][Full Text] [Related]
8. A new small molecule that directly inhibits the DNA binding of NF-kappaB.
Kobayashi T; Yoshimori A; Kino K; Komori R; Miyazawa H; Tanuma SI
Bioorg Med Chem; 2009 Jul; 17(14):5293-7. PubMed ID: 19539480
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two DNase gamma-specific monoclonal antibodies and the in situ detection of DNase gamma in the nuclei of apoptotic rat thymocytes.
Shiokawa D; Tanaka M; Kimura T; Hashizume K; Takasawa R; Ohyama H; Fujita K; Yamada T; Tanuma S
Biochem Biophys Res Commun; 2000 Aug; 275(2):343-9. PubMed ID: 10964668
[TBL] [Abstract][Full Text] [Related]
10. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
Zhou Z; Bates M; Madura JD
Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
[TBL] [Abstract][Full Text] [Related]
11. Structure of the carboxypeptidase Y inhibitor IC in complex with the cognate proteinase reveals a novel mode of the proteinase-protein inhibitor interaction.
Mima J; Hayashida M; Fujii T; Narita Y; Hayashi R; Ueda M; Hata Y
J Mol Biol; 2005 Mar; 346(5):1323-34. PubMed ID: 15713484
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
[TBL] [Abstract][Full Text] [Related]
13. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
14. Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity.
Popov VM; Yee WA; Anderson AC
Proteins; 2007 Feb; 66(2):375-87. PubMed ID: 17078091
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: a novel and potential antifolate lead for Pf-DHFR-TS inhibition.
Gahtori P; Ghosh SK; Parida P; Prakash A; Gogoi K; Bhat HR; Singh UP
Exp Parasitol; 2012 Mar; 130(3):292-9. PubMed ID: 22233734
[TBL] [Abstract][Full Text] [Related]
16. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
Frembgen-Kesner T; Elcock AH
J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling, agonist binding site identification, and docking in octopamine receptor of Periplaneta americana.
Hirashima A; Huang H
Comput Biol Chem; 2008 Jun; 32(3):185-90. PubMed ID: 18430608
[TBL] [Abstract][Full Text] [Related]
18. Involvement of DNase gamma in the resected double-strand DNA breaks in immunoglobulin genes.
Okamoto M; Okamoto N; Yashiro H; Shiokawa D; Sunaga S; Yoshimori A; Tanuma S; Kitamura D
Biochem Biophys Res Commun; 2005 Feb; 327(1):76-83. PubMed ID: 15629432
[TBL] [Abstract][Full Text] [Related]
19. A phospho-sugar binding domain homologous to NagB enzymes regulates the activity of the central glycolytic genes repressor.
Doan T; Martin L; Zorrilla S; Chaix D; Aymerich S; Labesse G; Declerck N
Proteins; 2008 Jun; 71(4):2038-50. PubMed ID: 18186488
[TBL] [Abstract][Full Text] [Related]
20. DNase II is a member of the phospholipase D superfamily.
Cymerman IA; Meiss G; Bujnicki JM
Bioinformatics; 2005 Nov; 21(21):3959-62. PubMed ID: 16150810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
